Soleus Capital Management, L.P.
Net seller this quarter
$2.9B
97
-$186M
48.9%
Holdings
| Company | Value | % of portfolio | % of company | POSITION CHANGE qoq % | First reported |
|---|---|---|---|---|---|
| Q2 2026 | |||||
 KRYS | $349M | 12.03% | 3.17% | -18.5% | Q1 2021 |
 CELC | $178M | 6.14% | 3.48% | +32.7% | Q2 2021 |
 TGTX | $161M | 5.54% | 1.91% | -27.3% | Q4 2022 |
 PODD | $160M | 5.50% | 1.51% | +86.5% | Q2 2020 |
 NVCR | $150M | 5.18% | 8.51% | -5.5% | Q1 2020 |
 UTHR | $122M | 4.21% | 0.53% | +20.5% | Q3 2021 |
 INSP | $86.2M | 2.97% | 6.68% | +235.1% | Q4 2019 |
 RIGL | $72.1M | 2.49% | 9.96% | +18335.0% | Q1 2023 |
 ANIP | $71.8M | 2.48% | 3.86% | +5.8% | Q3 2024 |
 BBNX | $68.8M | 2.37% | 9.77% | +0.9% | Q1 2025 |
 VCEL | $64.9M | 2.24% | 2.85% | -42.8% | Q4 2019 |
 PRAX | $59.4M | 2.05% | 0.64% | -46.3% | Q2 2023 |
 GERN | $54.8M | 1.89% | 6.67% | +3.1% | Q1 2025 |
 ALKS | $53.9M | 1.86% | 0.61% | -47.8% | Q1 2023 |
 ERAS | $49.5M | 1.70% | 0.86% | Not reported | Q2 2024 |
 NPCE | $46.3M | 1.59% | 8.49% | -0.7% | Q2 2021 |
 PGNY | $46.2M | 1.59% | 2.07% | -22.5% | Q1 2026 |
 INDV | $43.7M | 1.50% | 0.87% | -16.5% | Q2 2023 |
 PBLS | $40.1M | 1.38% | 1.20% | New | Q2 2026 |
 FOCL | $37.9M | 1.30% | 19.48% | Not reported | Q1 2021 |
 GMED | $37M | 1.28% | 0.35% | -35.7% | Q2 2024 |
 RCUS | $36M | 1.24% | 0.92% | +158.6% | Q4 2025 |
 SNDX | $35.6M | 1.23% | 1.83% | -5.7% | Q4 2019 |
 NRIX | $35.5M | 1.22% | 1.41% | +56.2% | Q3 2021 |
 LEGN | $34.8M | 1.20% | 0.33% | New | Q2 2026 |
 JBIO | $34.5M | 1.19% | 2.44% | +94.6% | Q2 2025 |
 UNH | $33.3M | 1.15% | 0.01% | Not reported | Q1 2020 |
 AVTX | $30.6M | 1.05% | 3.13% | +274.5% | Q4 2021 |
 URGN | $30.5M | 1.05% | 1.70% | +14.1% | Q3 2023 |
 MBX | $28.4M | 0.98% | 1.07% | +188.0% | Q3 2025 |
 PALI | $27.3M | 0.94% | 7.53% | New | Q2 2026 |
 PHVS | $25.3M | 0.87% | 1.12% | +4.1% | Q4 2022 |
 ORGO | $24.6M | 0.85% | 7.88% | +0.6% | Q3 2021 |
 SUPN | $24.2M | 0.83% | 0.89% | Not reported | Q1 2022 |
 PRCT | $22.6M | 0.78% | 1.75% | +526.9% | Q3 2021 |
 TNGX | $22.2M | 0.76% | 0.42% | +57.6% | Q2 2023 |
 IKT | $22.1M | 0.76% | 8.24% | Not reported | Q4 2024 |
 TRVI | $22M | 0.76% | 0.83% | -27.2% | Q2 2025 |
 BMRN | $21.5M | 0.74% | 0.19% | -42.3% | Q2 2023 |
 LIVN | $21M | 0.72% | 0.46% | -56.2% | Q1 2025 |
 ARGX | $18.5M | 0.64% | 0.03% | +470.1% | Q4 2019 |
 NVCT | $18.4M | 0.63% | 3.75% | New | Q2 2026 |
 CAPR | $18.3M | 0.63% | 1.31% | Not reported | Q4 2025 |
 EWTX | $18.3M | 0.63% | 0.42% | -68.9% | Q1 2021 |
 PRLD | $18M | 0.62% | 4.24% | New | Q2 2026 |
 XENE | $16.1M | 0.56% | 0.28% | -8.6% | Q4 2019 |
 CCCC | $15.8M | 0.54% | 2.75% | -11.2% | Q1 2021 |
 KNSA | $15.8M | 0.54% | Not reported | -52.8% | Q2 2023 |
 KIDS | $14M | 0.48% | 2.85% | +19.0% | Q4 2022 |
 AVLN | $13.8M | 0.48% | 0.95% | New | Q2 2026 |
| Q1 2026 | |||||
| KRYS | $298M | 12.06% | 3.92% | +22.5% | Q1 2021 |
| CELC | $147M | 5.94% | 2.66% | -29.0% | Q2 2021 |
| TGTX | $134M | 5.42% | 2.63% | +28.4% | Q4 2022 |
| PODD | $118M | 4.78% | 0.80% | +275.0% | Q2 2020 |
| NVCR | $114M | 4.63% | 9.06% | +23.0% | Q1 2020 |
| UTHR | $111M | 4.50% | 0.44% | +212.0% | Q3 2021 |
| PRAX | $106M | 4.31% | 1.19% | -8.9% | Q2 2023 |
| VCEL | $82M | 3.32% | 5.00% | +233.7% | Q4 2019 |
| ALKS | $69.7M | 2.82% | 1.18% | +49.0% | Q1 2023 |
| ANIP | $63.1M | 2.55% | 3.65% | +68.7% | Q3 2024 |
| GMED | $62.9M | 2.55% | 0.54% | -17.8% | Q2 2024 |
| GERN | $61.8M | 2.50% | 6.48% | +78.2% | Q1 2025 |
 TWST | $58.3M | 2.36% | 1.97% | -34.1% | Q2 2023 |
| EWTX | $45.7M | 1.85% | 1.35% | +59.3% | Q1 2021 |
| BBNX | $43.6M | 1.77% | 9.77% | +71.8% | Q1 2025 |
 ALNY | $43.6M | 1.76% | 0.10% | +88.1% | Q3 2022 |
| SNDX | $40.3M | 1.63% | 1.95% | -23.2% | Q4 2019 |
| INDV | $38.8M | 1.57% | 1.02% | +1174.0% | Q2 2023 |
| NPCE | $38.6M | 1.56% | 8.65% | +8.5% | Q2 2021 |
| LIVN | $37M | 1.50% | 1.06% | +2.6% | Q1 2025 |
 MIRM | $37M | 1.50% | 0.66% | -30.2% | Q1 2022 |
| BMRN | $36.8M | 1.49% | 0.34% | -50.7% | Q2 2023 |
| PGNY | $35.1M | 1.42% | 2.64% | New | Q1 2026 |
| INSP | $29.7M | 1.20% | 2.00% | +92.5% | Q4 2019 |
| FOCL | $27.2M | 1.10% | 19.50% | Not reported | Q1 2021 |
| KNSA | $25.1M | 1.02% | Not reported | -11.2% | Q2 2023 |
 MRK | $24.4M | 0.99% | 0.01% | Not reported | Q3 2020 |
| ORGO | $23.9M | 0.97% | 7.84% | +1.0% | Q3 2021 |
 NTRA | $23.8M | 0.96% | 0.08% | +495.0% | Q4 2019 |
 AXGN | $22.5M | 0.91% | 1.28% | -43.7% | Q4 2019 |
 PCVX | $22.4M | 0.91% | 0.27% | -36.7% | Q1 2021 |
 ICLR | $21.2M | 0.86% | 0.25% | New | Q1 2026 |
| PHVS | $19.8M | 0.80% | 1.08% | Not reported | Q4 2022 |
 CERS | $19.6M | 0.79% | 5.60% | +168.8% | Q4 2025 |
| TRVI | $19.3M | 0.78% | 1.26% | +80.0% | Q2 2025 |
| IKT | $18.3M | 0.74% | 8.24% | Not reported | Q4 2024 |
 CNTX | $18.2M | 0.74% | 7.58% | New | Q1 2026 |
 VIR | $17.9M | 0.73% | 1.24% | New | Q1 2026 |
| XENE | $17M | 0.69% | 0.30% | Not reported | Q4 2019 |
 TVTX | $16.2M | 0.66% | 0.59% | Not reported | Q3 2021 |
 TNDM | $15M | 0.61% | 1.14% | Not reported | Q4 2019 |
| NRIX | $14.5M | 0.59% | 0.91% | -23.1% | Q3 2021 |
| URGN | $13.1M | 0.53% | 1.49% | +384.7% | Q3 2023 |
 SION | $11.8M | 0.48% | 0.65% | +9.3% | Q1 2025 |
 CORT | $11.5M | 0.47% | 0.27% | Not reported | Q3 2021 |
| JBIO | $11.2M | 0.45% | 1.61% | Not reported | Q2 2025 |
 VCYT | $10.3M | 0.42% | 0.40% | +3099.1% | Q3 2024 |
 IVVD | $10M | 0.41% | 2.73% | Not reported | Q4 2025 |
| CCCC | $10M | 0.41% | 3.66% | Not reported | Q1 2021 |
| KIDS | $9.77M | 0.40% | 2.43% | +17.1% | Q4 2022 |
| Q4 2025 | |||||
| KRYS | $232M | 8.56% | 3.22% | -7.6% | Q1 2021 |
| CELC | $180M | 6.65% | 3.75% | +53.4% | Q2 2021 |
| NVCR | $110M | 4.07% | 7.58% | -11.6% | Q1 2020 |
| PRAX | $107M | 3.95% | 1.44% | -57.8% | Q2 2023 |
| TGTX | $93.6M | 3.45% | 2.02% | -18.4% | Q4 2022 |
 DXCM | $86.1M | 3.18% | 0.34% | Not reported | Q4 2019 |
| BMRN | $78.4M | 2.89% | 0.69% | +48.3% | Q2 2023 |
| GMED | $77.4M | 2.86% | 0.66% | +404.0% | Q2 2024 |
| BBNX | $77.2M | 2.85% | 5.71% | -34.5% | Q1 2025 |
| FOLD | $74.2M | 2.74% | 1.68% | +11.0% | Q4 2019 |
| TWST | $59.1M | 2.18% | 3.04% | -0.2% | Q2 2023 |
| ORGO | $51.7M | 1.91% | 7.87% | -17.7% | Q3 2021 |
| SNDX | $47.2M | 1.74% | 2.57% | +11.7% | Q4 2019 |
| MIRM | $45.3M | 1.67% | 1.11% | +285.8% | Q1 2022 |
| PODD | $42.6M | 1.57% | 0.21% | Not reported | Q2 2020 |
| NPCE | $41.7M | 1.54% | 8.05% | -8.6% | Q2 2021 |
| AXGN | $39.5M | 1.46% | 2.56% | -30.1% | Q4 2019 |
| ANIP | $38.4M | 1.42% | 2.16% | +42.9% | Q3 2024 |
| ALKS | $37M | 1.36% | 0.80% | Not reported | Q1 2023 |
| LIVN | $34.9M | 1.29% | 1.04% | Not reported | Q1 2025 |
 GSK | $31.3M | 1.16% | 0.01% | +190.5% | Q3 2023 |
| GERN | $30.7M | 1.13% | 3.64% | +34.7% | Q1 2025 |
| UTHR | $29.2M | 1.08% | 0.14% | -60.0% | Q3 2021 |
 IMVT | $28.2M | 1.04% | 0.55% | Not reported | Q2 2023 |
| PCVX | $28.1M | 1.04% | 0.46% | Not reported | Q1 2021 |
| ALNY | $27.8M | 1.03% | 0.05% | +359.0% | Q3 2022 |
| INSP | $27.6M | 1.02% | 1.05% | -58.9% | Q4 2019 |
| VCEL | $27.5M | 1.01% | 1.51% | +53.4% | Q4 2019 |
| ARGX | $26.7M | 0.98% | 0.05% | -54.3% | Q4 2019 |
| RAPT | $25.9M | 0.95% | 2.76% | +42.0% | Q2 2020 |
 NBIX | $25M | 0.92% | 0.18% | +27.5% | Q3 2025 |
| KNSA | $24.2M | 0.89% | Not reported | +291.3% | Q2 2023 |
| FOCL | $24M | 0.89% | 19.50% | Not reported | Q1 2021 |
 TFX | $23.2M | 0.86% | 0.43% | New | Q4 2025 |
| NRIX | $23.1M | 0.85% | 1.20% | -49.7% | Q3 2021 |
| EWTX | $22.6M | 0.83% | 0.86% | Not reported | Q1 2021 |
| IKT | $22.3M | 0.82% | 8.26% | +71.9% | Q4 2024 |
| PHVS | $19.5M | 0.72% | 1.08% | +8.5% | Q4 2022 |
| IVVD | $19M | 0.70% | 2.73% | New | Q4 2025 |
| CAPR | $18.7M | 0.69% | 1.13% | New | Q4 2025 |
 THC | $18.4M | 0.68% | 0.11% | Not reported | Q4 2024 |
| RCUS | $17M | 0.63% | 0.57% | New | Q4 2025 |
 ELVN | $15.8M | 0.58% | 1.72% | Not reported | Q2 2024 |
| MBX | $12.9M | 0.48% | 0.91% | +48.7% | Q3 2025 |
| RIGL | $12.9M | 0.47% | 1.64% | -9.1% | Q1 2023 |
| JBIO | $12.3M | 0.45% | 1.62% | Not reported | Q2 2025 |
| TRVI | $11.3M | 0.42% | 0.70% | +3500.0% | Q2 2025 |
| SION | $11M | 0.41% | 0.60% | -35.1% | Q1 2025 |
 SEPN | $10.7M | 0.39% | 0.86% | +1999.5% | Q4 2024 |
| KIDS | $9.33M | 0.34% | 2.09% | +310.5% | Q4 2022 |
| Q3 2025 | |||||
| KRYS | $180M | 9.05% | 3.52% | +10.4% | Q1 2021 |
| TGTX | $139M | 6.99% | 2.48% | +71.3% | Q4 2022 |
| NVCR | $125M | 6.27% | 8.61% | +39.7% | Q1 2020 |
 ELV | $83.9M | 4.22% | 0.12% | +270.9% | Q3 2024 |
| BBNX | $76.9M | 3.87% | 8.80% | +1.3% | Q1 2025 |
| UTHR | $62.9M | 3.17% | 0.35% | -28.5% | Q3 2021 |
| TERN | $61M | 3.07% | 9.29% | -0.5% | Q2 2024 |
| CELC | $58.2M | 2.93% | 2.72% | -60.9% | Q2 2021 |
| INSP | $54M | 2.72% | 2.51% | +568.1% | Q4 2019 |
| TWST | $52.5M | 2.64% | 3.08% | +426.6% | Q2 2023 |
| ARGX | $51.2M | 2.58% | 0.11% | +61.9% | Q4 2019 |
| ORGO | $51.2M | 2.58% | 9.56% | -1.7% | Q3 2021 |
| BMRN | $48.2M | 2.43% | 0.46% | -1.3% | Q2 2023 |
| CDTX | $47.3M | 2.38% | 1.68% | +6.7% | Q2 2025 |
| PRAX | $45.5M | 2.29% | 4.06% | -11.1% | Q2 2023 |
| FOLD | $37M | 1.86% | 1.52% | Not reported | Q4 2019 |
| INDV | $35.3M | 1.78% | 1.18% | Not reported | Q2 2023 |
 MDGL | $31.3M | 1.58% | 0.30% | +754.2% | Q4 2024 |
| ANIP | $31.2M | 1.57% | 1.61% | +570.5% | Q3 2024 |
| SNDX | $31M | 1.56% | 2.32% | +84.2% | Q4 2019 |
| AXGN | $30.8M | 1.55% | 3.74% | +18.3% | Q4 2019 |
| NPCE | $30.5M | 1.54% | 8.89% | +27.9% | Q2 2021 |
 GRFS | $24.9M | 1.25% | Not reported | -56.6% | Q4 2019 |
| GERN | $23.7M | 1.19% | 2.71% | +7.1% | Q1 2025 |
| NRIX | $22.4M | 1.13% | 3.15% | Not reported | Q3 2021 |
 IART | $20.6M | 1.04% | 1.85% | +3.8% | Q4 2024 |
| NBIX | $19.4M | 0.98% | 0.14% | New | Q3 2025 |
 ANAB | $19.2M | 0.97% | 2.27% | +95.0% | Q3 2022 |
| FOCL | $16.7M | 0.84% | 19.55% | Not reported | Q1 2021 |
| PHVS | $16.1M | 0.81% | 1.19% | -11.7% | Q4 2022 |
| VCEL | $15.7M | 0.79% | 0.99% | +877.3% | Q4 2019 |
| CCCC | $15.7M | 0.79% | 9.51% | +1.1% | Q1 2021 |
 BLTE | $15.5M | 0.78% | 0.66% | New | Q3 2025 |
| VCYT | $14.5M | 0.73% | 0.53% | -41.0% | Q3 2024 |
| RAPT | $13.9M | 0.70% | 3.25% | Not reported | Q2 2020 |
| URGN | $13.5M | 0.68% | 1.45% | -68.9% | Q3 2023 |
 STAA | $13.4M | 0.68% | 1.01% | -83.3% | Q4 2019 |
| SION | $12.2M | 0.61% | 0.93% | +10.0% | Q1 2025 |
 CGON | $11.7M | 0.59% | 0.37% | +87.1% | Q1 2024 |
 QURE | $11.7M | 0.59% | 0.32% | New | Q3 2025 |
 QDEL | $11M | 0.56% | 0.55% | +115.5% | Q2 2020 |
| MIRM | $10.9M | 0.55% | 0.29% | -50.2% | Q1 2022 |
 ADMA | $10.8M | 0.54% | 0.31% | +321.7% | Q2 2025 |
| IKT | $10.2M | 0.52% | 8.46% | Not reported | Q4 2024 |
| GMED | $10.1M | 0.51% | 0.13% | Not reported | Q2 2024 |
| GSK | $9.5M | 0.48% | 0.01% | Not reported | Q3 2023 |
| RIGL | $9.35M | 0.47% | 1.84% | -49.9% | Q1 2023 |
 EOLS | $8.9M | 0.45% | 2.24% | -31.6% | Q2 2021 |
 VSTM | $8.26M | 0.42% | 1.40% | Not reported | Q4 2021 |
| ACLX | $8.21M | 0.41% | 0.17% | -18.7% | Q1 2022 |